Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching
全基因组 CRISPR-Cas9 筛选发现,抑制 CLK1 可通过 ERCC1 亚型转换恢复 PARP 抑制剂敏感性。
期刊:Protein & Cell
影响因子:12.8
doi:10.1093/procel/pwaf091
Liu, Chaohua; Xu, Fei; Wu, Yutuan; Li, Jiana; Ni, Mengdong; Xia, Siyu; Chen, Lihua; Zhao, Haiyun; Yu, Min; Zhou, Yuqi; Zhang, Meiqin; Li, Jiajia; Wu, Xiaohua; Huang, Yan; Zhu, Tao; Chen, Xiaojun